Free Trial

Sylvania Platinum (SLP) Competitors

Sylvania Platinum logo
GBX 71 +1.00 (+1.43%)
As of 06:08 AM Eastern

SLP vs. DOCS, WIX, YOU, CNIC, SRAD, NET, GVP, ARBB, CYN, and INSE

Should you be buying Sylvania Platinum stock or one of its competitors? The main competitors of Sylvania Platinum include Dr. Martens (DOCS), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), Stelrad Group (SRAD), Netcall (NET), Gabelli Value Plus+ Trust (GVP), Arbuthnot Banking Group (ARBB), CQS Natural Resources Growth and Income (CYN), and Inspired (INSE). These companies are all part of the "computer software" industry.

Sylvania Platinum vs.

Sylvania Platinum (LON:SLP) and Dr. Martens (LON:DOCS) are both small-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, community ranking, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Dr. Martens has a consensus price target of GBX 6,000, indicating a potential upside of 7,466.20%. Given Dr. Martens' stronger consensus rating and higher probable upside, analysts plainly believe Dr. Martens is more favorable than Sylvania Platinum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sylvania Platinum
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Sylvania Platinum has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500.

17.8% of Sylvania Platinum shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 12.2% of Sylvania Platinum shares are held by insiders. Comparatively, 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sylvania Platinum pays an annual dividend of GBX 2 per share and has a dividend yield of 2.7%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 3.8%. Sylvania Platinum pays out 93.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Dr. Martens is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Dr. Martens had 28 more articles in the media than Sylvania Platinum. MarketBeat recorded 29 mentions for Dr. Martens and 1 mentions for Sylvania Platinum. Dr. Martens' average media sentiment score of 0.44 beat Sylvania Platinum's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sylvania Platinum
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Dr. Martens
2 Very Positive mention(s)
12 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sylvania Platinum has a net margin of 8.55% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Sylvania Platinum's return on equity.

Company Net Margins Return on Equity Return on Assets
Sylvania Platinum8.55% 2.82% 1.69%
Dr. Martens 7.89%18.91%8.12%

Sylvania Platinum received 223 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 84.62% of users gave Dr. Martens an outperform vote while only 79.59% of users gave Sylvania Platinum an outperform vote.

CompanyUnderperformOutperform
Sylvania PlatinumOutperform Votes
234
79.59%
Underperform Votes
60
20.41%
Dr. MartensOutperform Votes
11
84.62%
Underperform Votes
2
15.38%

Dr. Martens has higher revenue and earnings than Sylvania Platinum. Dr. Martens is trading at a lower price-to-earnings ratio than Sylvania Platinum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sylvania Platinum£99.97M2.36£8.54M£2.1334.21
Dr. Martens£874.20M0.88£68.97M£7.0511.24

Summary

Dr. Martens beats Sylvania Platinum on 13 of the 19 factors compared between the two stocks.

Get Sylvania Platinum News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLP vs. The Competition

MetricSylvania PlatinumOther Precious Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£235.59M£316.11M£3.20B£2.94B
Dividend Yield4.06%6.06%5.04%4.90%
P/E Ratio34.2115.4169.48124.70
Price / Sales2.3610,308,865.0228,196,331,330,659,000.00243,902.77
Price / Cash2.1913.1024.2628.11
Price / Book0.8510.005.374.74
Net Income£8.54M-£2.74M£155.01M£5.92B
7 Day Performance20.07%5.17%1.65%7.21%
1 Month Performance55.32%15.00%6.56%17.10%
1 Year Performance17.74%29.03%21.06%82.84%

Sylvania Platinum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLP
Sylvania Platinum
N/AGBX 71
+1.4%
N/A+12.9%£229.13M£99.97M33.27160
DOCS
Dr. Martens
3.2396 of 5 stars
GBX 59.55
+1.1%
GBX 6,000
+9,975.6%
-5.3%£578.09M£874.20M8.44890Earnings Report
Dividend Cut
WIX
Wickes Group
1.7184 of 5 stars
GBX 226.50
+2.5%
GBX 215
-5.1%
+60.6%£536.28M£1.45B18.315,930
YOU
YouGov
2.8928 of 5 stars
GBX 322.50
-0.6%
GBX 880
+172.9%
-59.7%£377.37M£335.28M-164.361,820Trending News
CNIC
CentralNic Group
N/AN/AN/AN/A£339.82M£790.04M-12,660.00100
SRAD
Stelrad Group
N/AGBX 141
+0.7%
N/A+21.4%£187.32M£306.97M12.122,960
NET
Netcall
1.8803 of 5 stars
GBX 104
+0.5%
GBX 130
+25.0%
+25.8%£171.91M£39.16M29.293,220
GVP
Gabelli Value Plus+ Trust
N/AN/AN/AN/A£155.29MN/A0.00310Gap Down
ARBB
Arbuthnot Banking Group
N/AGBX 940
+1.1%
N/A+1.8%£152.15M£239.83M4.97799High Trading Volume
CYN
CQS Natural Resources Growth and Income
N/AGBX 200
+1.3%
N/A+4.6%£125.76M£12.63M14.2140Positive News
INSE
Inspired
N/AGBX 74
-2.0%
N/A-12.5%£118.14M£155.87M67.761,600News Coverage

Related Companies and Tools


This page (LON:SLP) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners